Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01965769 · ClinicalTrials.gov registry record · NA

Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT01965769: Completed NA study, sponsored by University of Florida.

NCT01965769 is a NA study that has completed, run by University of Florida. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01965769, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

Omitting evaluation of gastric residual contents prior to feeding very premature infants will increase the feeding intake at 2 weeks, and total caloric intake and growth by 3 weeks, as well as decrease the time required for parenteral nutrition.

Interventions

  • OTHER No gastric residual evaluation

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2011-03
Est. Completion 2013-10
Phase NA
University of Florida

1,106 total trials

What the finished NCT01965769 record still lists

NCT01965769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which No gastric residual evaluation is the first listed.

NCT01965769 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01965769 about?

NCT01965769 is a clinical study titled "Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS". Omitting evaluation of gastric residual contents prior to feeding very premature infants will increase the feeding intake at 2 weeks, and total caloric intake and growth by 3 weeks, as well as decrease the time required for parenteral nutrition.

What is the current status of trial NCT01965769?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2011-03. Estimated completion is 2013-10.

What interventions are being tested in trial NCT01965769?

The interventions under investigation include: No gastric residual evaluation (OTHER).

Who is sponsoring clinical trial NCT01965769?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01965769's enrollment target sits among peer trials

61 1164th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01965769, the US trial registry maintained by the National Library of Medicine. NCT01965769 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.